Printing tool Download PDF


Respected Public Health Scientist with over 15 years of experience leading development and management of large-scale domestic and international epidemiological and surveillance programs and projects. Superlative team coordination, negotiation, and public relations strengths; easily fosters and sustains productive relationships across multiple federal agencies and high-profile scientific / research organizations. Exemplary service as a Captain for U.S. Public Health Service, coordinating and supervising initiatives to address challenging high priority public health issues. Excellent writing and communications skills with over 50 peer-reviewed and a host of government publications, websites and materials to her credit.

Core competencies include:

·Strategic Program Planning*Interagency Collaborations*Public and Media Relations*Community Health Education*Performance Metrics & Analysis*Public Health Response*Team Building & Leadership*Process Redesign & Change Management    *Project Management


Aug 1993May 1998

PhD Biochemistry and Molecular Biology

Emory University

BDissertation: An Analysis of Phospholipid Transport in S. cerevisiae

N.I.H. Predoctoral Training Grant;N.I.H. Minority Predoctoral Fellowship

Aug 1989May 1993

BS Biochemistry (Major) Nutrition (Minor)

Rutgers University

National Merit Scholarship; James D. Carr Scholarship

Teaching and Mentoring Experience

Georgia Gwinnett College, Part Time Faculty of Biology (July 2017- Current)

  • Teach required college-level Biology courses to a diverse population of undergraduate students.
  • Teach both majors and non-majors as well as laboratory sections.
  • Design syllabus, select materials and deliver content for courses.
  • Evaluates students to measure their progress in achieving institutional and course goals.

Kaplan University, Online, Adjunct Instructor (Nov 2011 – April 2012)

  • Taught Master of Public Health Capstone Course online for two terms.
    • Led students through development and implementation of Capstone Projects for MPH
    • Developed rubrics for assessments and graded projects throughout each step of development as well as final project
    • Conducted live real-time presentation and discussions online at least once a week
  • Taught Chronic Disease Epidemiology for MPH program students for 1 term
    • Led and graded online discussions based in preset syllabus and course content
    • Graded projects and final papers
    • Did live real-time presentation and discussions online at least once a week

University of Maryland University College, Adelphi, MD, Adjunct Instructor (Fall 2007)

  • Taught Biology course to undergraduate students online.
  • Designed syllabus and course objectives.
  • Researched, wrote, and conducted all course lectures.
  • Wrote, administered, and graded all examinations.

University of New Haven, West Haven, CT, Adjunct Instructor (Jan 1999 – April 1999)

  • Taught Biochemistry of Bioenergetics course to graduate students.
  • Designed syllabus and course objectives.
  • Researched, wrote, and conducted all course lectures.
  • Wrote, administered, and graded all examinations.
  • Engaged student’s interest by incorporating current health, nutrition, and genetic disorders into biochemistry lectures.

Emory University, Atlanta, GA , Teaching Assistant   (January 1995 – May 1995)

  • Led review sessions, facilitated a weekly discussion group on the primary literature, and graded examinations for graduate-level metabolism course.

Public Health Mentoring and Training:

  • Secondary Supervisor - Epidemic Intelligence Service (2013-2014) Fellow: Lauren Marcewicz, MD
  • Primary Supervisor - Epidemic Intelligence Service (2011-2013) Fellow: Charlotte Baker, PhD
  • Primary Supervisor -Epidemic Intelligence Service (2010-2012), Fellow: Ijeoma Azonobi, MD MPH
  • Mentor - David J. Sencer CDC Museum Summer Internship (Summer 2012): Student: Amelia Watson
  • Mentor and Capstone Project Supervisor (Summer 2010) Student: Demetrice Morrison, MPH, Barry University
  • Thesis Committee and Capstone Project Supervisor -(2011-2013), Student: Tierney Bell, MPH Morehouse School of Medicine MPH program
  • Mentor -  Ferguson Fellowship Program  (Summer 2008); Mentee: Kerry-Ann Kelly, MPH

Work experience

May 2014Present

Senior Advisor for Science for the Deputy Director for Non-Infectious Disease

Centers for Disease Control and Prevention

Serves as principal scientific advisor for the Deputy Director for Non-Infectious Disease. Coordinates agency activities for cross-cutting public health priorities including marijuana use, alcohol-related harms, mental health as well as other emerging behavioral health issues. For these cross-cutting scientific areas, leads strategic planning, monitors and facilitates the implementation of plans, fosters cross-agency and interagency collaboration, maintains situational awareness, writes, reviews, and edits documents, webpages and reports, and regularly updates Deputy Director, Director , partners and CDC scientists regarding the status of initiatives. Provide scientific assistance to non-infectous disease programs, connecting them to resources to support their work, assistance with strategic planning and scientific review as needed.

 Selected accomplishments:

  • Coordinated CDC’s Marijuana cross-agency workgroup and led workgroup in development of agency plan for marijuana and public health
  • Led development of CDC’s first marijuana and public health webpages ( ) released in 2017
  • Coordinated multiagency public-private sponsorship and co-wrote the statement of work for the National Academy of Science report “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research” which was released in January 2017 (
  • Coordinated development of surveillance modules for monitoring health effects of marijuana in several national surveillance systems including Behavioral Risk Factor Surveillance System (BRFSS) and Pregnancy Risk Assessment Monitoring System (PRAMS).
  • Served as Principal Agency representative for the development of Surgeon General Report on Alcohol Drugs and Health (see
Aug 2010May 2014


Centers for Disease Control and Prevention

• Directed strategy development, policy formation, and programs related to blood disorders.
• Supervised three staff teams tasked with epidemiological research, public health surveillance, and capacity building for public health programs.
• Conceptualized and develop public health projects of national and international scope; served as scientific subject matter expert, key advisor to Division Director and official Division spokesperson on all blood disorder program areas.
• Managed $14-million budget; ensured compliance with human subjects protections, publication clearance, and reporting requirements.
• Presented at national and international conferences;
• coordinated multidisciplinary workgroups, expert panels, and stakeholder meetings.
• As Project Director, worked closely with sister federal agencies on collaborative initiatives. Selected accomplishments:

  • Established first global health initiatives for hemoglobinopathies, successfully developing collaborations with Ghana, Nigeria, and Kenya to improve screening and care of people with blood disorders.
  • Initiated collaboration with World Health Organization EMRO to build capacity for screening and treatment of hemoglobinopathies in 22 EMRO countries.
  • Developed and hosted first International Public Health Learning Collaborative for Hemoglobinopathies, attracting participants from 25 US states and five countries.
Jul 2004Aug 2010


Centers for Disease Control and Prevention

Advanced in 2007 based on success as Epidemiologist to lead staff of 15 scientists assigned to Epidemiology and Surveillance team within Division of Blood Disorders. Coordinated and directed nationwide epidemiological research studies of hereditary and other blood disorders; provided oversight of intramural projects and developed / reviewed new grant opportunities for external investigators. Contributed to strategic planning, implementation, and evaluation of scientific phases of Division programs. Liaised effectively with world experts, public health agencies, and non-governmental organizations to optimize management of programs, systems, and strategies for surveillance of blood disorders, improve data quality, and heighten program accountability. Selected accomplishments:

  • Secured $11-million interagency agreement between NIH and CDC to establish first national surveillance system for hemoglobinopathies.
  • Spearheaded cutting-edge epidemiological research and surveillance across 7 program areas accounting for 60% of division budget.
  • Created division's first sickle cell disease (SCD) program.
  • As Epidemiologist and Principal Investigator, obtained funding through competitive intramural RFA mechanisms for proposal to conduct research in the area of genetics and preterm birth and for proposal to build laboratory capacity for integration of genetics and biomarkers into studies of preterm delivery.
  • Built collaboration with external partners including the California Department of Health to use state-based biobanks to conduct large population-based investigations of preterm delivery among multiple racial and ethnic groups.
    Jul 2002Jun 2004


    Centers for Disease Control and Prevention

    Structured and conducted national field investigations of potentially serious public health issues. Performed comprehensive epidemiological studies; analyzed new and pre-existing public health data. Addressed public health inquires from the public, media, government officials, and health professionals; authored and submitted scientific manuscripts to MMWR and peer-reviewed journals. Selected accomplishments:

    • As Lead Investigator, conducted thorough study of HIV infection among sexually active adolescents in Georgia ultimately published in Pediatrics.
    • Performed study of infant health among Puerto Ricans in Puerto Rico and on the U.S. mainland.
    • Evaluated National Pregnancy Mortality Surveillance System (NPMSS).
    Jul 2002Present


    Commissioned Corps of the U.S. Public Health Service

    Coordinate and execute swift responses to rising public health emergencies. Maintain all training, fitness, and readiness standards required for active service. Selected accomplishments: • Deputy Team Leader, Regional Incident Support Team IV: Headed provision of rapid assessments and initial incident response to state, tribal, and local health authorities within defined regions of the United States. • West Nile Virus Investigation: Served as Co-investigator on scientific team tasked with researching causes of West Nile Virus (WNV) transmitted through blood transfusions and coordinating follow-up efforts of physicians, state and local health department, and blood banking facilities. • Hurricane Katrina: As member of Resilience and Mental Health Team assigned to the Director's Emergency Operations Center (DEOC), monitored mental health and resilience activities in the field • Earned public health service awards and commendations for outstanding service in key projects, including developing sickle cell disease programs, protecting the health of citizens following Hurricanes Katrina, Rita, and Wilma, improving understanding of HIV infection among adolescents, and contributing to response to West Nile virus outbreak.

    Early Experience

    Scientific Curator for Incyte Genomics, Beverly, MA (1998-2002), Research Assistant for Centers for Disease Control and Prevention, Atlanta, GA (2001), and Adjunct Professor at University of New Haven, West Haven, CT (1999).

    Other Training

    Jan 2015Jun 2015

    Six Sigma Black Belt

    Clayton State University

    A comprehensive, hands-on orientation to the Six Sigma Black Belt body of knowledge-as enriched by the Instructor, Technology, DMAIC Tools, and participants' experiences.

    Jan 2014Mar 2014

    Six Sigma Green Belt

    Clayton State University

    A comprehensive, hands-on orientation to the Six Sigma Green Belt body of knowledge-as enriched by the Instructor, Technology, DMAIC Tools, and participants' experiences.

    Aug 1999Dec 2002

    Public Health Coursework

    Emory University

    Advanced graduate  coursework in Statistics, Epidemiology, Environmental Health,  Infectious Diseases, and Public Health Policy.


    US Public Health Service

    • 2016. Presidential Unit Citation – U.S.  Public Health Service. In Recognition of: United States Government response to Ebola outbreak from 09/2014-05/2015
    • 2014. Unit Commendation – U.S.  Public Health Service. In Recognition of: Outstanding Service to the SCD Community via the development of activities aimed at increasing awareness at the local and national level from 01/2013-09/2013
    • 2014. Unit Commendation – U.S.  Public Health Service. In Recognition of: Outstanding performance, participation, and effective preparedness in response activities from 10/2009-09/2013
    • 2010. Special Assignment Award - U.S. Public Health Service. In Recognition of: Completion of all requirements of the three-years participation on Tier I or Tier II response teams from 06/2006-07/2009
    • 2009. Commendation Medal - U.S.  Public Health Service. In recognition for developing programs to improve the health of individuals affected by sickle cell disease from February 2007 to July 2009.
    • 2007. Outstanding Unit Citation - U.S.  Public Health Service. In Recognition of: Protecting the health of citizens of Louisiana, Florida, Texas and Mississippi after Hurricanes Katrina, Rita and Wilma from 08/2005 to 03/2006
    • 2006. Achievement Medal - U.S.  Public Health Service. In Recognition of: Exemplary contributions to improving understanding of HIV infection among adolescents and for leadership in the development of preterm birth research agenda
    • 2006. Crisis Response Service Award - U.S.  Public Health Service. In Recognition of: Protecting the health of citizens of Louisiana, Florida, Texas and Mississippi after Hurricanes Katrina, Rita and Wilma from 08/2005 to 02/2006
    • 2005. Outstanding Unit Citation - U.S. Public Health Service. In Recognition of: Response to the 2002 West Nile virus outbreak in the United States from 08/2002 to 12/2003
    • 2003. Commissioned Corps Training Ribbon - U.S.  Public Health Service. In Recognition of: Successfully completed all requirements for the Basic Officer Training Course and Independent Officer Training Course


    • 2013 Atlanta Federal Executive Board Outstanding Team – Winner
    • 2012 National Center on Birth Defects and Developmental Disabilities Outstanding Team Award
    • 2009 Atlanta Federal Executive Board Outstanding Team - Nominee
    • 2003. CDC and ATSDR Honor Awards: CDC, NCID “Partners in Public Health – West Nile Virus”


    Journal Articles

    1. Manco-Johnson MJ, Byams VR, Recht M, Dudley B, Dupervil B, Aschman DJ, Oakley M, Kapica S, Voutsis M, Humes S, Kulkarni R, Grant AM; U.S. Haemophilia Treatment Center Network. Community counts: Evolution of a national surveillance system for bleeding disorders. Am J Hematol. 2018 Jun;93(6):E137-E140. doi: 10.1002/ajh.25076. Epub 2018 Apr 28
    2. Tsai J, Rolle IV, Singh T, Boulet SL, McAfee TA, Grant AM. Patterns of marijuana and tobacco use associated with suboptimal self-rated health among US adult ever users of marijuana. Prev Med Rep. 2017 Mar 23;6:251-257. doi: 10.1016/j.pmedr.2017.03.014. eCollection 2017 Jun.
    3. Clayton HB, Lowry R, Ashley C, Wolkin A, Grant AM. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana. Pediatrics 2017 Mar 13, e20162675; DOI: 10.1542/peds.2016-2675 [Epub ahead of print].
    4. Marcewicz LH, Anderson BL, Byams VR, Grant AM, Schulkin J. Screening and Treatment for Iron Deficiency Anemia in Women: Results of a Survey of Obstetrician-Gynecologists. Matern Child Health J. 2017 Feb 27. doi: 10.1007/s10995-016-2252-1. [Epub ahead of print] .
    5. Marcewicz LH, Clayton J, Maenner M, Odom E, Okoroh E, Christensen D, Goodman A, Warren MD, Traylor J, Miller A, Jones T, Dunn J, Schaffner W, Grant A. Parental Refusal of Vitamin K and Neonatal Preventive Services: A Need for Surveillance. Matern Child Health J. 2017 Jan 4. doi: 10.1007/s10995-016-2205-8. [Epub ahead of print]
    6. Azofeifa A, Mattson ME, Grant A. Monitoring Marijuana Use in the United States: Challenges in an Evolving Environment. JAMA. 2016 Nov 1;316(17):1765-1766.
    7. Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014. MMWR Surveill Summ. 2016 Sep 2;65(11):1-28
    8. Anie KA, Treadwell MJ, Grant AM, Dennis-Antwi JA, Asafo MK, Lamptey ME, Ojodu J, Yusuf C, Otaigbe A, Ohene-Frempong K. Community engagement to inform the development of a sickle cell counselor training and certification program in Ghana. J Community Genet. 2016 Jul;7(3):195-202.
    9. Paulukonis ST, Eckman JR, Snyder AB, Hagar W, Feuchtbaum LB, Zhou M, Grant AM, Hulihan MM. Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008. Public Health Rep. 2016 Mar-Apr;131(2):367-75.
    10. Baker C, Grant AM, George MG, Grosse SD, Adamkiewicz TV. Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012. Pediatr Blood Cancer. 2015 Dec;62(12):2076-81.
    11. Tsai J, Grant AM, Beckman MG, Grosse SD, Yusuf HR, Richardson LC. Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysis. PLoS One. 2015 Apr 16;10(4):e0123842.
    12. Lewis DA, Suchindran S, Beckman MG, Hooper WC, Grant AM, Heit JA, Manco-Johnson M, Moll S, Philipp CS, Kenney K, De Staercke C, Pyle ME, Chi JT, Ortel TL. Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res. 2015 Apr;135(4):659-65.
    13. Ojodu J, Hulihan MM, Pope SN, Grant AM; Centers for Disease Control and Prevention (CDC). Incidence of sickle cell trait--United States, 2010. MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1155-8.
    14. Azonobi IC, Anderson BL, Byams VR, Grant AM, Schulkin J. Obstetrician-gynecologists' knowledge of sickle cell disease screening and management. BMC Pregnancy Childbirth. 2014 Oct 14;14:356.
    15. Wang Y, Liu G, Caggana M, Kennedy J, Zimmerman R, Oyeku SO, Werner EM, Grant AM, Green NS, Grosse SD. Mortality of New York children with sickle cell disease identified through newborn screening. Genet Med. 2015 Jun;17(6):452-9.
    16. Beckman MG, Hulihan MM, Byams VR, Oakley MA, Reyes N, Trimble S, Grant AM. Public health surveillance of nonmalignant blood disorders. Am J Prev Med. 2014 Nov;47(5):664-8.
    17. Treadwell MJ, Anie KA, Grant AM, Ofori-Acquah SF, Ohene-Frempong K. Using formative research to develop a counselor training program for newborn screening in Ghana. J Genet Couns. 2015 Apr;24(2):267-77.
    18. Hulihan MM, Feuchtbaum L, Jordan L, Kirby RS, Snyder A, Young W, Greene Y, Telfair J, Wang Y, Cramer W, Werner EM, Kenney K, Creary M, Grant AM. State-based surveillance for selected hemoglobinopathies. Genet Med. 2015 Feb;17(2):125-30.
    19. Mainous AG 3rd, Wright RU, Hulihan MM, Twal WO, McLaren CE, Diaz VA, McLaren GD, Argraves WS, Grant AM. Elevated transferrin saturation, health-related quality of life and telomere length. Biometals. 2014 Feb;27(1):135-41.
    20. Philipp CS, Faiz AS, Beckman MG, Grant A, Bockenstedt PL, Heit JA, James AH, Kulkarni R, Manco-Johnson MJ, Moll S, Ortel TL. Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome. Thromb Res. 2014 Jan;133(1):108-11.
    21. Tsai J, Grant AM, Soucie JM, Helwig A, Yusuf HR, Boulet SL, Reyes NL, Atrash Clustering patterns of comorbidities associated with in-hospital death in hospitalizations of US adults with venous thromboembolism. Int J Med Sci. 2013 Aug 19;10(10):1352-60.
    22. Tsai J, Abe K, Boulet SL, Beckman MG, Hooper WC, Grant AM. Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism. PLoS One. 2013 Jul 26;8(7):e70061.
    23. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA; CDC Thalassemia Investigators. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014 Apr;54(4):972-81; quiz 971.
    24. Grosse SD, Boulet SL, Grant AM, Hulihan MM, Faughnan ME. The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia. Genet Med. 2014 Jan;16(1):33-9.
    25. Mainous AG 3rd, Wright RU, Hulihan MM, Twal WO, McLaren CE, Diaz VA, McLaren GD, Argraves WS, Grant AM. Telomere length and elevated iron: the influence of phenotype and HFE genotype. Am J Hematol. 2013 Jun;88(6):492-6.
    26. Landi D, Beckman MG, Shah NR, Bockenstedt P, Grant AM, Heit JA, Key NS, Kulkarni R, Manco-Johnson M, Moll S, Philipp CS, Andersen JC, Ortel TL. Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost. 2013 Apr;109(4):625-32.
    27. Boulet SL, Okoroh EM, Azonobi I, Grant A, Craig Hooper W. Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population. Matern Child Health J. 2013 Feb;17(2):200-7.
    28. Mainous AG 3rd, Diaz VA, Knoll ME, Hulihan MM, Grant AM, Wright RU. Transferrin Saturation and Hospital Length of Stay and Mortality in Medicare Beneficiaries. J Am Geriatr Soc. 2012. Jan;61(1):132-6
    29. Wang Y, Kennedy J, Caggana M, Zimmerman R, Thomas S, Berninger J, Harris K, Green NS, Oyeku S, Hulihan M, Grant AM, Grosse SD. Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Genet Med. 2013 Mar;15(3):222-8.
    30. Byams VR, Anderson BL, Grant AM, Atrash H, Schulkin J. Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists. Am J Obstet Gynecol. 2012 Oct;207(4):269.e1-5.
    31. Tsai J, Grosse SD, Grant AM, Reyes NL, Hooper WC, Atrash HK. Correlates of in-hospital deaths among hospitalizations with pulmonary embolism: findings from the 2001-2008 National Hospital Discharge Survey. PLoS One. 2012;7(7):e34048. Epub 2012 Jul 6.
    32. Mainous AG 3rd, Knoll ME, Everett CJ, Hulihan MM, Grant AM, Garrison C, Koenig G, Sayers C, Allen KW. A national survey of hemochromatosis patients. J Am Board Fam Med. 2012 Jul;25(4):432-6.
    33. Okoroh EM, Azonobi IC, Grosse SD, Grant AM, Atrash HK, James AH. Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011. J Womens Health (Larchmt). 2012 Jun;21(6):611-5.
    34. Tsai J, Grosse SD, Grant AM, Hooper WC, Atrash HK. Trends in In-Hospital Deaths Among Hospitalizations With Pulmonary Embolism. Arch Intern Med. 2012 Jun 25;172 (12):960-1
    35. Kharrazi M, Pearl M, Yang J, DeLorenze GN, Bean CJ, Callaghan WM, Grant A, Lackritz E, Romero R, Satten GA, Simhan H, Torres AR, Westover JB, Yolken R, and Williamson DM. California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case–control study. Paediatric and Perinatal Epidemiology. 2012;26(3):250–263.
    36. Mainous AG 3rd, Weinberg ED, Diaz VA, Johnson SP, Hulihan MM, Grant AM. Calcium channel blocker use and serum ferritin in adults with hypertension. Biometals. 2012 May;25:563-68
    37. Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA, Goldsmith JC, Atrash HK. Public Health Implications of Sickle Cell Trait A Report of the CDC Meeting. Am J Prev Med. 2011 Dec;41(6 Suppl 4):S435-9.
    38. Beckman MG, Grosse SD, Kenney KM, Grant AM, Atrash HK. Developing public health surveillance for deep vein thrombosis and pulmonary embolism. Am J Prev Med. 2011 Dec;41(6 Suppl 4):S428-34.
    39. Hulihan MM, Sayers CA, Grosse SD, Garrison C, Grant AM. Iron overload what is the role of public health? Am J Prev Med. 2011 Dec;41(6 Suppl 4):S422-7.
    40. Jordan LB, Smith-Whitley K, Treadwell MJ, Telfair J, Grant AM, Ohene-Frempong K. Screening U.S. College athletes for their sickle cell disease carrier status. Am J Prev Med. 2011 Dec;41(6 Suppl 4):S406-12.
    41. Yusuf HR, Lloyd-Puryear MA, Grant AM, Parker CS, Creary MS, Atrash HK. Sickle cell disease the need for a public health agenda. Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83.
    42. Kharrazi M, Pearl M, Yang J, DeLorenze GN, Bean CJ, Callaghan WM, Grant A, Lackritz E, Romero R, Satten G, Simhan H, Torres AR, Westover JB; Yolken R, and Williamson DM. California Very Preterm Birth Study: Design and characteristics of a population- and biospecimen bank-based nested case-control study. Paediatric and Perinatal Epidemiology, in press.
    43. Byams VR, Kouides PA, Kulkarni R, Baker JR, Brown DL, Gill JC, Grant AM, James AH, Konkle BA, Maahs J, Dumas MM, McAlister S, Nance D, Nugent D, Philipp CS, Soucie JM, Stang E; Haemophilia Treatment Centres Network Investigators. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia. 2011 Jul;17 Suppl 1:6-13.
    44. Mainous AG 3rd, Diaz VA, Everett CJ, Knoll ME, Hulihan MM, Grant AM, McLaren CE, McLaren GD. IRon overload screeNing tool (IRON): Development of a tool to guide screening in primary care. Am J Hematol. 2011 Sep;86(9):733-7
    45. Hinton CF, Grant AM, Grosse SD. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening. Ethn Health. 2011 Aug-Oct;16(4-5):377-88.
    46. Mainous AG 3rd, Knoll ME, Everett CJ, Matheson EM, Hulihan MM, Grant AM. Uric Acid as a potential cue to screen for iron overload. J Am Board Fam Med. 2011 Jul-Aug;24(4):415-21.
    47. Yusuf HR, Atrash HK, Grosse SD, Parker CS, Grant AM. Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007. Am J Prev Med 2010;38:S536-41.
    48. Trimble SR, Parker CS, Grant AM, Soucie JM, Reyes N. Assessing emerging infectious threats to blood safety for the blood disorders community. Am J Prev Med 2010;38:S468-74.
    49. Heit JA, Beckman MG, Bockenstedt PL, et al. Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol 2010;85:467-71.
    50. Byams VR, Beckman MG, Grant AM, Parker CS. Developing a public health research agenda for women with blood disorders. J Womens Health (Larchmt) 2010;19:1231-4.
    51. Robitaille J, Grant AM. The genetics of gestational diabetes mellitus: evidence for relationship with type 2 diabetes mellitus. Genet Med 2008;10:240-50.
    52. Beckman MG, Critchley SE, Hooper WC, Grant AM, Kulkarni R. CDC Division of Blood Disorders: public health research activities in venous thromboembolism. Arterioscler Thromb Vasc Biol 2008;28:394-5.
    53. Grant AM, Jamieson DJ, Elam-Evans LD, Beck-Sague C, Duerr A, Henderson SL. Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection. Pediatrics 2006;117:e468-75.
    54. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
    55. Hanson PK, Grant AM, Nichols JW. NBD-labeled phosphatidylcholine enters the yeast vacuole via the pre-vacuolar compartment. J Cell Sci 2002;115:2725-33.
    56. Grant AM, Hanson PK, Malone L, Nichols JW. NBD-labeled phosphatidylcholine and phosphatidylethanolamine are internalized by transbilayer transport across the yeast plasma membrane. Traffic 2001;2:37-50.
    57. Guo W, Grant A, Novick P. Exo84p is an exocyst protein essential for secretion. J Biol Chem 1999;274:23558-64.
    58. Siegmund A, Grant A, Angeletti C, Malone L, Nichols JW, Rudolph HK. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. J Biol Chem 1998;273:34399-405.
    59. Decottignies A, Grant AM, Nichols JW, de Wet H, McIntosh DB, Goffeau A. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 1998;273:12612-22.
    60. Kean LS, Grant AM, Angeletti C, et al. Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3. J Cell Biol 1997;138:255-70

    Book Chapters/Books

    • Merrill AH Grant, A, Wang E, Bacon CW. Lipids and lipid-like compounds of Fusarium. In: Ghannoum RPaMA, ed. Lipids of Pathogenic Fungi. Boca Raton, Florida: CRC Press, Inc.; 1996:199-216

    Government Publications

    • Nimia L. Reyes, Scott D. Grosse, Althea M. Grant (2016) Deep Vein Thrombosis & Pulmonary Embolism. In Gary W. Brunette, MD, MPH (Ed.) CDC Health Information for International Travel. Retrieved from
    • Streiff MB, Brady JP, Grant AM, Grosse SD, Wong B, Popovic T; Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: preventing hospital-associated venous thromboembolism. MMWR Morb Mortal Wkly Rep. 2014 Mar7;63(9):190-3.
    • Nimia L. Reyes, Scott D. Grosse, Althea M. Grant (2014) Deep Vein Thrombosis & Pulmonary Embolism. In Gary W. Brunette, MD, MPH (Ed.) CDC Health Information for International Travel.
    • Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children Sickle Cell Disease Carrier Screening Workgroup Members. Screening U.S. College Athletes for Their Sickle Cell Disease Carrier Status; 2010.
    • Centers for Disease Control and Prevention. Rates of Cesarean Delivery Among Puerto Rican Women --- Puerto Rico and the U.S. Mainland, 1992--2002. Morbidity and Mortality Weekly Report 2006;55:68-71.


    • Grant AM. An Analysis of The Mechanisms of Phospholipid Transport in S. Cerevisiae. Atlanta, GA: Emory University; 1998.